We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Promising New Imaging Technology for Diagnosis of Cardiovascular Disease, Diabetes

By HospiMedica International staff writers
Posted on 05 Jul 2011
Researchers have developed a new type of imaging technology to diagnose cardiovascular disease and other disorders by measuring ultrasound signals from molecules exposed to a fast-pulsing laser. More...


The new method could be used to take precise three-dimensional (3D) images of plaques lining arteries, according to Dr. Ji-Xin Cheng, an associate professor of biomedical engineering and chemistry at Purdue University (West Lafayette, IN, USA). Other imaging modalities that provide molecular data are unable to penetrate tissue deep enough to reveal the three-dimensional structure of the plaques, but being able to do so would make better diagnoses possible, he said. "You would have to cut a cross section of an artery to really see the three-dimensional structure of the plaque," Dr. Cheng said. "Obviously, that can't be used for living patients."

The imaging reveals the presence of carbon-hydrogen bonds comprising lipid molecules in arterial plaques that cause heart disease. The method also might be used to detect fat molecules in muscles to diagnose diabetes and for other lipid-related disorders, including neurologic disorders and brain trauma. The technique also reveals nitrogen-hydrogen bonds making up proteins, meaning the imaging tool also might be useful for diagnosing other diseases and to study collagen's role in scar formation. "Being able to key on specific chemical bonds is expected to open a completely new direction for the field," Dr. Cheng said

Findings are detailed in an article published June 17, 2011, in the journal Physical Review Letters. The findings represent the culmination of four years of research led by Dr. Cheng and doctoral student Han-Wei Wang.

The new technique uses nanosecond laser pulses in the near-infrared range of the spectrum. The laser generates molecular "overtone" vibrations, or wavelengths that are not absorbed by the blood. The pulsed laser causes tissue to heat and expand locally, generating pressure waves at the ultrasound frequency that can be picked up with a device called a transducer. "We are working to miniaturize the system so that we can build an endoscope to put into blood vessels using a catheter," Dr. Cheng said. "This would enable us to see the exact nature of plaque formation in the walls of arteries to better quantify and diagnose cardiovascular disease."

Dr. Lihong Wang, a professor of biomedical engineering at Washington University in St. Louis (MO, USA), is a pioneer of using the photoacoustic imaging of blood vessels based on the absorption of light by the electrons in hemoglobin.

The Purdue researchers are the first to show that a strong photoacoustic signal can arise from the absorption of light by the chemical bonds in molecules. The near-infrared laser causes enough heating to generate ultrasound but not enough to damage tissue. "You can measure the time delay between the laser and the ultrasound waves, and this gives you a precise distance, which enables you to image layers of the tissues for three-dimensional pictures," Dr. Cheng said. "You do one scan and get all the cross sections. Our initial target is cardiovascular disease, but there are other potential applications, including diabetes and neurological conditions."

The approach represents a major improvement over another imaging technique, called coherent anti-Stokes Raman scattering (CARS), which has been used by the Purdue-based lab to study 3D plaque formation in arteries.

The study's findings are based on research with pig tissues in laboratory samples and also with live fruit flies. "You can see fat inside fly larvae, representing the potential to study how obesity affects physiology in humans," Dr. Cheng noted.

Related Links:
Purdue University



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.